Tech Company Financing Transactions
Astrocyte Pharmaceuticals Funding Round
DeepWork Capital, Angel Star Ventures and private investors invested in a $9.5 million Series B funding round for Astrocyte Pharmaceuticals. This VC investment round was recorded on 9/30/2026.
Transaction Overview
Company Name
Announced On
9/30/2026
Transaction Type
Venture Equity
Amount
$9,500,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to advance the continued Phase 2 clinical development of AST-004, including completion of the STARFAST trial in sports-related concussion in Australian Rules Football.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
93 Shennecossett Rd.
Groton, CT 06340
USA
Groton, CT 06340
USA
Phone
Website
Email Address
Overview
Astrocyte Pharmaceuticals Inc. is a small drug development company dedicated to clinically proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Korinek
Co-Founder
James Lechleiter
VP - Manufacturing
Russell Poe
VP - R & D
Theodore Liston
Browse more venture capital transactions:
Prev: 9/30/2026: Ray Therapeutics venture capital transaction
Next: 9/30/2026: Tryp.com venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs